Alkermes Plc reports results for the quarter ended June 30 - Earnings Summary
Alkermes Plc reports results for the quarter ended June 30 - Earnings Summary
Alkermes Plc ALKS.OQ reported quarterly breakeven results per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 67 cents. The mean expectation of seventeen analysts for the quarter was for a loss of 2 cents per share. Wall Street expected results to range from -18 cents to 25 cents per share.
Revenue rose 27% to $496.01 million from a year ago; analysts expected $457.82 million.
Alkermes Plc's reported EPS for the quarter was breakeven results.
The company reported quarterly net income of $501 thousand.
Alkermes Plc shares had risen by 0.6% this quarter and gained 88.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 40.2% in the last three months.
In the last 30 days, three analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy," 4 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"
Wall Street's median 12-month price target for Alkermes Plc is $56.00, about 5.8% above its last closing price of $52.73
This summary was machine generated from LSEG data July 28 at 01:32 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.02 | 0.00 | Beat |
Mar. 31 2026 | -0.57 | -0.40 | Beat |
Dec. 31 2025 | 0.34 | 0.29 | Missed |
Sep. 30 2025 | 0.30 | 0.49 | Beat |